287 related articles for article (PubMed ID: 15781870)
1. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.
Malley R; Trzcinski K; Srivastava A; Thompson CM; Anderson PW; Lipsitch M
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4848-53. PubMed ID: 15781870
[TBL] [Abstract][Full Text] [Related]
2. Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.
Basset A; Thompson CM; Hollingshead SK; Briles DE; Ades EW; Lipsitch M; Malley R
Infect Immun; 2007 Nov; 75(11):5460-4. PubMed ID: 17698570
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17A mediates acquired immunity to pneumococcal colonization.
Lu YJ; Gross J; Bogaert D; Finn A; Bagrade L; Zhang Q; Kolls JK; Srivastava A; Lundgren A; Forte S; Thompson CM; Harney KF; Anderson PW; Lipsitch M; Malley R
PLoS Pathog; 2008 Sep; 4(9):e1000159. PubMed ID: 18802458
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model.
Trzcinski K; Thompson C; Malley R; Lipsitch M
Infect Immun; 2005 Oct; 73(10):7043-6. PubMed ID: 16177389
[TBL] [Abstract][Full Text] [Related]
5. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
Malley R; Srivastava A; Lipsitch M; Thompson CM; Watkins C; Tzianabos A; Anderson PW
Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
[TBL] [Abstract][Full Text] [Related]
7. Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge.
Zhang Y; Masi AW; Barniak V; Mountzouros K; Hostetter MK; Green BA
Infect Immun; 2001 Jun; 69(6):3827-36. PubMed ID: 11349048
[TBL] [Abstract][Full Text] [Related]
8. Generation of protective pneumococcal-specific nasal resident memory CD4
O'Hara JM; Redhu NS; Cheung E; Robertson NG; Patik I; Sayed SE; Thompson CM; Herd M; Lucas KB; Conaway E; Morton CC; Farber DL; Malley R; Horwitz BH
Mucosal Immunol; 2020 Jan; 13(1):172-182. PubMed ID: 31659300
[TBL] [Abstract][Full Text] [Related]
9. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells.
Trzciński K; Thompson CM; Srivastava A; Basset A; Malley R; Lipsitch M
Infect Immun; 2008 Jun; 76(6):2678-84. PubMed ID: 18391006
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
[TBL] [Abstract][Full Text] [Related]
11. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model.
Green BA; Zhang Y; Masi AW; Barniak V; Wetherell M; Smith RP; Reddy MS; Zhu D
Infect Immun; 2005 Feb; 73(2):981-9. PubMed ID: 15664941
[TBL] [Abstract][Full Text] [Related]
12. Endogenous IL-1R1 signaling is critical for cognate CD4+ T cell help for induction of in vivo type 1 and type 2 antipolysaccharide and antiprotein Ig isotype responses to intact Streptococcus pneumoniae, but not to a soluble pneumococcal conjugate vaccine.
Chen Q; Sen G; Snapper CM
J Immunol; 2006 Nov; 177(9):6044-51. PubMed ID: 17056530
[TBL] [Abstract][Full Text] [Related]
13. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.
Malley R
J Mol Med (Berl); 2010 Feb; 88(2):135-42. PubMed ID: 20049411
[TBL] [Abstract][Full Text] [Related]
14. Semisynthetic Glycoconjugate Vaccines To Elicit T Cell-Mediated Immune Responses and Protection against
Feng S; Xiong C; Wang S; Guo Z; Gu G
ACS Infect Dis; 2019 Aug; 5(8):1423-1432. PubMed ID: 31126171
[No Abstract] [Full Text] [Related]
15. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae.
Cui Y; Zhang X; Gong Y; Niu S; Yin N; Yao R; Xu W; Li D; Wang H; He Y; Cao J; Yin Y
Vaccine; 2011 Feb; 29(9):1736-44. PubMed ID: 21238570
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.
Malley R; Lipsitch M; Stack A; Saladino R; Fleisher G; Pelton S; Thompson C; Briles D; Anderson P
Infect Immun; 2001 Aug; 69(8):4870-3. PubMed ID: 11447162
[TBL] [Abstract][Full Text] [Related]
17. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice.
Kim EH; Choi SY; Kwon MK; Tran TD; Park SS; Lee KJ; Bae SM; Briles DE; Rhee DK
Vaccine; 2012 Mar; 30(11):2008-19. PubMed ID: 22154770
[TBL] [Abstract][Full Text] [Related]
20. Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant.
Malley R; Morse SC; Leite LC; Areas AP; Ho PL; Kubrusly FS; Almeida IC; Anderson P
Infect Immun; 2004 Jul; 72(7):4290-2. PubMed ID: 15213177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
